Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.


Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
19 Jun 2021
Historique:
received: 13 05 2021
revised: 15 06 2021
accepted: 16 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 15 12 2021
Statut: epublish

Résumé

Fabry disease is an X-linked disorder of α-galactosidase A (GLA) deficiency. Our previous interim analysis (1 July 2014 to 31 December 2015) revealed plasma globotriaosylsphingosine as a promising primary screening biomarker for Fabry disease probands. Herein, we report the final results, including patients enrolled from 1 January to 31 December 2016 for evaluating the potential of plasma globotriaosylsphingosine and GLA activity as a combined screening marker. We screened 5691 patients (3439 males) referred from 237 Japanese specialty clinics based on clinical findings suggestive of Fabry disease using plasma globotriaosylsphingosine and GLA activity as primary screening markers, and

Identifiants

pubmed: 34205365
pii: cimb43010032
doi: 10.3390/cimb43010032
pmc: PMC8928976
doi:

Substances chimiques

Biomarkers 0
Glycolipids 0
Sphingolipids 0
globotriaosyl lysosphingolipid 126550-86-5
alpha-Galactosidase EC 3.2.1.22

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-404

Subventions

Organisme : Sanofi K.K.
ID : J13K0104

Références

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7
pubmed: 18287059
J Genet Couns. 2016 Aug;25(4):731-41
pubmed: 27228983
Hum Mol Genet. 1994 Oct;3(10):1795-9
pubmed: 7531540
Lancet. 2005 Nov 19;366(9499):1794-6
pubmed: 16298216
Stroke. 2010 Mar;41(3):431-6
pubmed: 20110537
N Engl J Med. 1967 May 25;276(21):1163-7
pubmed: 6023233
Clin Genet. 2006 Apr;69(4):344-8
pubmed: 16630168
Am J Hum Genet. 1990 Nov;47(5):784-9
pubmed: 2171331
BMC Neurol. 2015 Dec 12;15:256
pubmed: 26652600
Appl Clin Genet. 2019 Mar 05;12:35-50
pubmed: 30881085
Hum Mol Genet. 2001 Apr 15;10(9):927-40
pubmed: 11309366
J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3563-3569
pubmed: 30201457
Front Genet. 2019 Sep 27;10:783
pubmed: 31611903
Kidney Int. 2017 Feb;91(2):284-293
pubmed: 27998644
Mol Genet Metab. 2020 Jul;130(3):209-214
pubmed: 32418857
J Appl Genet. 2018 Aug;59(3):253-268
pubmed: 29680930
Am J Med Genet A. 2009 Feb 15;149A(4):613-21
pubmed: 19267410
Mol Genet Metab. 2002 May;76(1):23-30
pubmed: 12175777
J Inherit Metab Dis. 2011 Apr;34(2):509-14
pubmed: 21229318
J Med Genet. 2020 Aug;57(8):542-551
pubmed: 32161151
Stroke. 2017 Jul;48(7):1766-1772
pubmed: 28596458
Int Heart J. 2016 Sep 28;57(5):637-9
pubmed: 27593536
Nucleic Acids Res. 2000 Nov 1;28(21):4364-75
pubmed: 11058137
Gene. 1994 Apr 20;141(2):171-7
pubmed: 8163185
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Hum Mutat. 2008 Feb;29(2):331
pubmed: 18205205
Stroke. 2013 Feb;44(2):340-9
pubmed: 23306324
Int J Cardiol. 2014 Dec 15;177(2):400-8
pubmed: 25442977
Genet Med. 2019 Jan;21(1):44-52
pubmed: 29543226
Nucleic Acids Res. 2007;35(18):5995-6003
pubmed: 17726045
Clin J Am Soc Nephrol. 2013 Apr;8(4):629-36
pubmed: 23307880
Eur J Med Genet. 2015 Dec;58(12):681-4
pubmed: 26520229
JIMD Rep. 2015;23:27-34
pubmed: 25772321
FEBS Lett. 1996 Sep 9;393(1):74-6
pubmed: 8804427
Clin Physiol Funct Imaging. 2009 May;29(3):177-80
pubmed: 19320660
Clin Genet. 2016 Sep;90(3):220-9
pubmed: 26831127
Clin Chim Acta. 2020 Feb;501:27-32
pubmed: 31770509
Mol Med. 2012 Jul 18;18:780-4
pubmed: 22437327
Am J Hum Genet. 2002 Apr;70(4):994-1002
pubmed: 11828341
PLoS Genet. 2013;9(8):e1003632
pubmed: 23935525
J Cardiol. 2013 Jul;62(1):63-9
pubmed: 23608164
J Med Genet. 1996 Aug;33(8):682-8
pubmed: 8863162
Mol Genet Metab Rep. 2018 Oct 26;17:73-79
pubmed: 30386727
Clin Chim Acta. 2015 Jul 20;447:96-104
pubmed: 26070511
Clin Neurol Neurosurg. 2013 Jul;115(7):1088-93
pubmed: 23219219
Mol Genet Metab. 2017 Aug;121(4):320-324
pubmed: 28663131
Orphanet J Rare Dis. 2020 Jan 29;15(1):30
pubmed: 31996269
Mol Med. 1997 Mar;3(3):174-82
pubmed: 9100224

Auteurs

Hiroki Maruyama (H)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Atsumi Taguchi (A)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Mariko Mikame (M)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Atsushi Izawa (A)

School of Health Sciences, Shinshu University, Matsumoto 390-8621, Japan.

Naoki Morito (N)

Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

Kazufumi Izaki (K)

Department of Pediatrics, Yao Municipal Hospital, Yao 581-0069, Japan.

Toshiyuki Seto (T)

Department of Medical Genetics, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.

Akifumi Onishi (A)

Department of Internal Medicine, Fukuyama City Hospital, Fukuyama 721-8511, Japan.

Hitoshi Sugiyama (H)

Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama 700-8558, Japan.

Norio Sakai (N)

Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.

Kenji Yamabe (K)

Department of Cardiology, Toyooka Hospital, Toyooka 668-8501, Japan.

Yukio Yokoyama (Y)

Division of Nephrology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan.

Satoshi Yamashita (S)

Department of Cardiology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.

Hiroshi Satoh (H)

Department of Cardiology, Fujinomiya City Hospital, Fujinomiya 418-0076, Japan.

Shigeru Toyoda (S)

Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu 321-0293, Japan.

Michihiro Hosojima (M)

Department of Clinical Nutrition Science, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Yumi Ito (Y)

Department of Health Promotion Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Ryushi Tazawa (R)

Health Administration Center, Student Support and Health Administration Organization, Tokyo Medical and Dental University, Bunkyo-ku 113-8510, Japan.

Satoshi Ishii (S)

GlycoPharma Corporation, Oita 870-0822, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH